ClinicalTrials.Veeva

Menu
P

PreCare Trial & Recruitment | Born, Netherlands

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Semaglutide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight....

Begins enrollment this month
Obesity
Type 2 Diabetes
Drug: Cagrisema
Drug: Semaglutide

The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight. There are 2...

Enrolling
Obesity
Drug: NNC0487-0111
Drug: Placebo (matched to NNC0487-0111)

Trial sponsors

Novo Nordisk logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems